Search research articles
Contact Us
Filters
Showing results (1-10 of 7) with videos related to
Page
of 1
Sort By:
Spinal Cord Series and Cases
|
October 22, 2019
Risk-benefit value of upper extremity function by an implanted electrical stimulation device targeting chronic cervical spinal cord injury
Kim D Anderson, Anne M Bryden, Megan Moynahan
Journal of the American College of Cardiology
|
December 20, 2005
Cardiac resynchronization devices: the Food and Drug Administration's regulatory considerations
Megan Moynahan, Owen P Faris, Brian M Lewis
Congestive Heart Failure (Greenwich, Conn.)
|
August 18, 2005
A US Food and Drug Administration perspective on cardiac resynchronization and ventricular assist device trials
Owen Faris, Eric Chen, Michael Berman, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders
|
March 20, 2016
Decision analysis of retrievable inferior vena cava filters in patients without pulmonary embolism
Jose Pablo Morales, Xuefeng Li, Telba Z Irony, et al.
Journal of Vascular Surgery
|
May 22, 2002
Preclinical testing for aortic endovascular grafts: results of a Food and Drug Administration workshop
Dorothy B Abel, Hugh G Beebe, Mark M Dedashtian, et al.
JAMA
|
April 28, 2006
Pacemaker and ICD generator malfunctions: analysis of Food and Drug Administration annual reports
William H Maisel, Megan Moynahan, Bram D Zuckerman, et al.
Bioelectronic Medicine
|
April 2, 2020
Proceedings of the second biennial Cleveland Neural Engineering Workshop 2013
Kim Anderson, Abidemi Ajiboye, Timothy Denison, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 7) with videos related to
Sort By:
Page
of 1
Spinal Cord Series and Cases
|
October 22, 2019
Risk-benefit value of upper extremity function by an implanted electrical stimulation device targeting chronic cervical spinal cord injury
Kim D Anderson, Anne M Bryden, Megan Moynahan
Journal of the American College of Cardiology
|
December 20, 2005
Cardiac resynchronization devices: the Food and Drug Administration's regulatory considerations
Megan Moynahan, Owen P Faris, Brian M Lewis
Congestive Heart Failure (Greenwich, Conn.)
|
August 18, 2005
A US Food and Drug Administration perspective on cardiac resynchronization and ventricular assist device trials
Owen Faris, Eric Chen, Michael Berman, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders
|
March 20, 2016
Decision analysis of retrievable inferior vena cava filters in patients without pulmonary embolism
Jose Pablo Morales, Xuefeng Li, Telba Z Irony, et al.
Journal of Vascular Surgery
|
May 22, 2002
Preclinical testing for aortic endovascular grafts: results of a Food and Drug Administration workshop
Dorothy B Abel, Hugh G Beebe, Mark M Dedashtian, et al.
JAMA
|
April 28, 2006
Pacemaker and ICD generator malfunctions: analysis of Food and Drug Administration annual reports
William H Maisel, Megan Moynahan, Bram D Zuckerman, et al.
Bioelectronic Medicine
|
April 2, 2020
Proceedings of the second biennial Cleveland Neural Engineering Workshop 2013
Kim Anderson, Abidemi Ajiboye, Timothy Denison, et al.
Page
of 1